JPWO2022034889A1 - - Google Patents

Info

Publication number
JPWO2022034889A1
JPWO2022034889A1 JP2022542858A JP2022542858A JPWO2022034889A1 JP WO2022034889 A1 JPWO2022034889 A1 JP WO2022034889A1 JP 2022542858 A JP2022542858 A JP 2022542858A JP 2022542858 A JP2022542858 A JP 2022542858A JP WO2022034889 A1 JPWO2022034889 A1 JP WO2022034889A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022542858A
Other languages
Japanese (ja)
Other versions
JPWO2022034889A5 (https=
JP7721539B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022034889A1 publication Critical patent/JPWO2022034889A1/ja
Publication of JPWO2022034889A5 publication Critical patent/JPWO2022034889A5/ja
Priority to JP2025126877A priority Critical patent/JP2025156408A/ja
Application granted granted Critical
Publication of JP7721539B2 publication Critical patent/JP7721539B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/02—Alkyl or cycloalkyl ethers
    • C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/14—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups
    • C08B11/15—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups with carbamoyl groups, i.e. -CO-NH2
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022542858A 2020-08-14 2021-08-10 多糖誘導体、多糖誘導体－薬物コンジュゲート、その製造方法 Active JP7721539B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025126877A JP2025156408A (ja) 2020-08-14 2025-07-30 多糖誘導体、多糖誘導体－薬物コンジュゲート、その製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020137010 2020-08-14
JP2020137010 2020-08-14
PCT/JP2021/029573 WO2022034889A1 (ja) 2020-08-14 2021-08-10 多糖誘導体、多糖誘導体－薬物コンジュゲート、その製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025126877A Division JP2025156408A (ja) 2020-08-14 2025-07-30 多糖誘導体、多糖誘導体－薬物コンジュゲート、その製造方法

Publications (3)

Publication Number Publication Date
JPWO2022034889A1 true JPWO2022034889A1 (https=) 2022-02-17
JPWO2022034889A5 JPWO2022034889A5 (https=) 2024-04-09
JP7721539B2 JP7721539B2 (ja) 2025-08-12

Family

ID=80247958

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022542858A Active JP7721539B2 (ja) 2020-08-14 2021-08-10 多糖誘導体、多糖誘導体－薬物コンジュゲート、その製造方法
JP2025126877A Pending JP2025156408A (ja) 2020-08-14 2025-07-30 多糖誘導体、多糖誘導体－薬物コンジュゲート、その製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025126877A Pending JP2025156408A (ja) 2020-08-14 2025-07-30 多糖誘導体、多糖誘導体－薬物コンジュゲート、その製造方法

Country Status (8)

Country Link
US (1) US20230285577A1 (https=)
EP (1) EP4198060A4 (https=)
JP (2) JP7721539B2 (https=)
KR (1) KR20230061346A (https=)
CN (2) CN116322642B (https=)
AU (1) AU2021324708A1 (https=)
CA (1) CA3188951A1 (https=)
WO (1) WO2022034889A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023157150A1 (ja) * 2022-02-16 2023-08-24 持田製薬株式会社 多糖誘導体の用途
CN115991883B (zh) * 2022-12-26 2024-07-16 四川大学华西医院 一种用于消化道esd的水凝胶及其制备方法和用途
CN120267903B (zh) * 2025-06-06 2025-08-08 吉林大学 一种免疫调控水凝胶及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120114602A1 (en) * 2009-06-16 2012-05-10 Fidia Farmaceutici S.P.A. Process for the synthesis of conjugates of glycosaminoglycanes (gag) with biologically active molecules, polymeric conjugates and relative uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
JP4565691B2 (ja) 2000-02-28 2010-10-20 株式会社Phg ヘパリン結合性成長因子用徐放基材、およびヘパリン結合性成長因子徐放剤
RU2283848C1 (ru) * 2005-06-16 2006-09-20 Институт нефтехимии и катализа РАН Республика Башкортостан Способ получения конъюгатов альгиновой кислоты
ITMI20061726A1 (it) * 2006-09-11 2008-03-12 Fidia Farmaceutici Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry
JPWO2008096547A1 (ja) * 2007-02-07 2010-05-20 焼津水産化学工業株式会社 組織滞留性キトサンゲルを含有する抗腫瘍剤組成物
WO2014038641A1 (ja) * 2012-09-05 2014-03-13 中外製薬株式会社 アミノ酸およびステリル基が導入されたヒアルロン酸誘導体
EP3778653B1 (en) 2018-03-28 2025-07-09 Mochida Pharmaceutical Co., Ltd. Novel reactive alginic acid derivatives
JP7088075B2 (ja) 2019-02-22 2022-06-21 株式会社デンソー 電子制御装置

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120114602A1 (en) * 2009-06-16 2012-05-10 Fidia Farmaceutici S.P.A. Process for the synthesis of conjugates of glycosaminoglycanes (gag) with biologically active molecules, polymeric conjugates and relative uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BUFFA,R. ET AL.: "Conjugates of modified hyaluronic acid with amino compounds for biomedical applications", CARBOHYDRATE POLYMERS, vol. 189, JPN6021037793, 2018, pages 273 - 279, XP055900331, ISSN: 0005497565, DOI: 10.1016/j.carbpol.2018.02.048 *
DELLACHERIE,E. ET AL.: "A new approach to aldehydic dextrans", POLYMER BULLETIN, vol. 31, no. 2, JPN6021037790, 1993, pages 145 - 149, XP000385692, ISSN: 0005497564, DOI: 10.1007/BF00329959 *
LI,N. ET AL.: "Using casein and oxidized hyaluronic acid to form biocompatible composite hydrogels for controlled d", MATERIALS SCIENCE & ENGINEERING, C, vol. 36, JPN6021037795, 2014, pages 287 - 293, ISSN: 0005497566 *
LIU,C. ET AL.: "Multifunctional PEG-grafted chitosan copolymer possessing amino and carboxyl (or formyl) groups", CENTRAL EUROPEAN JOURNAL OF CHEMISTRY, vol. 8, no. 3, JPN6021037792, 2010, pages 576 - 581, XP055900330, ISSN: 0005497563, DOI: 10.2478/s11532-010-0013-3 *

Also Published As

Publication number Publication date
CA3188951A1 (en) 2022-02-17
CN116322642B (zh) 2024-08-23
EP4198060A4 (en) 2024-09-04
EP4198060A1 (en) 2023-06-21
JP7721539B2 (ja) 2025-08-12
US20230285577A1 (en) 2023-09-14
AU2021324708A1 (en) 2023-03-09
JP2025156408A (ja) 2025-10-14
KR20230061346A (ko) 2023-05-08
WO2022034889A1 (ja) 2022-02-17
CN118955760A (zh) 2024-11-15
CN116322642A (zh) 2023-06-23

Similar Documents

Publication Publication Date Title
JPWO2022034889A1 (https=)
CN306014034S (https=)
CN305775778S (https=)
CN305533705S (https=)
CN305531677S (https=)
CN305531491S (https=)
CN305531118S (https=)
CN305529123S (https=)
CN305529858S (https=)
CN305529721S (https=)
CN305529483S (https=)
CN305529277S (https=)
CN305528197S (https=)
CN305527953S (https=)
CN305527518S (https=)
CN305527102S (https=)
CN305532049S (https=)
CN306347650S (https=)
CN305532136S (https=)
CN306063192S (https=)
CN306062725S (https=)
CN306061894S (https=)
CN306060968S (https=)
CN306060956S (https=)
CN306060866S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240328

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250306

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250701

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250730

R150 Certificate of patent or registration of utility model

Ref document number: 7721539

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150